Integrity Alliance LLC. Purchases 3,173 Shares of Danaher Corporation $DHR

Key Points

• Integrity Alliance LLC significantly increased its stake in Danaher Corporation by 191.4%, owning 4,831 shares valued at approximately $990,000 after acquiring additional shares in the first quarter.
• Danaher recently reported $1.80 earnings per share (EPS) for the last quarter, exceeding analyst estimates of $1.64, with a total revenue of $5.94 billion, which is a 3.4% increase year-over-year.
• The company announced a quarterly dividend of $0.32 per share to be paid on October 31st, reflecting an annualized payout of $1.28 with a yield of 0.7%.

Integrity Alliance LLC. boosted its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 191.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,831 shares of the conglomerate's stock after purchasing an additional 3,173 shares during the quarter. Integrity Alliance LLC.'s holdings in Danaher were worth $990,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Bank Pictet & Cie Europe AG grew its stake in shares of Danaher by 22.8% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after acquiring an additional 35,730 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Danaher by 7.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 63,534 shares of the conglomerate's stock worth $14,584,000 after purchasing an additional 4,388 shares during the last quarter. NorthRock Partners LLC grew its position in Danaher by 129.7% in the 4th quarter. NorthRock Partners LLC now owns 8,323 shares of the conglomerate's stock worth $1,910,000 after purchasing an additional 4,700 shares during the last quarter. ProShare Advisors LLC increased its holdings in shares of Danaher by 12.2% during the 4th quarter. ProShare Advisors LLC now owns 98,720 shares of the conglomerate's stock worth $22,661,000 after purchasing an additional 10,770 shares during the period. Finally, Point72 Asset Management L.P. raised its position in shares of Danaher by 460.6% during the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after buying an additional 1,107,998 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 11.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft lowered their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research report on Friday, July 11th. Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Finally, Evercore ISI lowered their price target on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Trading Up 1.8%

Danaher stock traded up $3.44 during trading hours on Tuesday, reaching $191.98. 1,870,859 shares of the company's stock traded hands, compared to its average volume of 4,130,194. The firm has a market capitalization of $137.47 billion, a price-to-earnings ratio of 40.83, a PEG ratio of 2.65 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The firm's 50 day moving average is $200.98 and its 200-day moving average is $198.64.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the firm posted $1.72 earnings per share. Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's payout ratio is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.